SCHEMBL4735608

SCHEMBL4735608

CC(C)NC(=O)[C@@H]1OC(C)O[C@H]1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 10/20 0.43
CAPN9 O14815 2/20 0.43
CTSB P07858 2/20 0.43
MAPK1 P28482 2/20 0.43
SUCNR1 Q9BXA5 1/20 0.41
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
CTSK P43235 3/20 0.36
TSHR P16473 2/20 0.36
CTSL P07711 1/20 0.36
CTSH P09668 1/20 0.36
CTSS P25774 1/20 0.36
CTSC P53634 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15171440 0.90 SUCNR1 (0.52) CAPN1CAPN9CTSBMAPK1SUCNR1
SCHEMBL31502886 0.78 SUCNR1 (0.65) SUCNR1TSHRLMNAALDH1A1
SCHEMBL16466637 0.77 CHRNB2 (0.37) CAPN1CAPN9CTSBMAPK1CHRNB2
SCHEMBL16639440 0.77 CHRNB2 (0.37) CAPN1CAPN9CTSBMAPK1CHRNB2
SCHEMBL16488393 0.71 CHRNB2 (0.36) CAPN1CAPN9CTSBMAPK1CHRNB2
SCHEMBL11183116 0.71 CAPN1 (0.40) CAPN1CAPN9CTSBMAPK1CHRNB2
SCHEMBL7615476 0.70 CAPN1 (0.58) CAPN1CAPN9CTSBMAPK1SUCNR1
SCHEMBL11063045 0.68 CAPN1 (0.68) CAPN1CAPN9CTSBMAPK1CTSK
SCHEMBL6741406 0.67 CAPN1 (0.58) CAPN1CAPN9CTSBMAPK1CTSK
SCHEMBL20179145 0.67 CAPN1 (0.66) CAPN1CAPN9CTSBMAPK1CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008078249-A1 ANTI-INFLAMMATORY AGENTS RANBAXY LABORATORIES LIMITED (IN) 2008-07-03 WO disclosed